β2-Microglobulin Elevates COL5A1 mRNA in the Subsynovial Connective Tissue of Patients Receiving Hemodialysis With Carpal Tunnel Syndrome.

Abstract

Background Although carpal tunnel syndrome (CTS) is frequently observed in patients undergoing long-term hemodialysis (HD), exactly how CTS arises is unknown. Here, we examined levels of COL5A1 in the subsynovial connective tissue (SSCT) of patients receiving HD and studied its potential regulation by β2-microglobulin (Β2-MG) in SSCT-derived cells (SSCTCs). Methods We extracted SSCT samples from 67 patients with CTS (49 non-HD and 18 HD) during carpal tunnel release. The samples were subjected to quantitative polymerase chain reaction (qPCR) to determine COL5A1 expression. Further, to examine the potential regulation of COL5A1 expression by Β2-MG, SSCTCs were stimulated in the absence (control) or presence of 10 µg/ml Β2-MG. Results The HD group showed significantly elevated COL5A1 levels compared to the non-HD group (P=0.027). Moreover, treating SSCTCs with Β2-MG for 24 h increased the mRNA expression of COL5A1 relative to control conditions (P=0.013). Conclusions Elevated COL5A1 expression may form part of the mechanism underlying the development of CTS, and Β2-MG may play a role in promoting COL5A1 expression in HD patients.

• Authors: Kyoko Muneshige, Kenji Onuma, Koji Sukegawa, Yuya Otake, Gen Inoue, Masashi Takaso, Kentaro Uchida
• Journal: Cureus (Cureus) Vol. 14 Issue 12 Pg. e32423 (Dec 2022) ISSN: 2168-8184 [Print] United States
• PMID: 36514703 (Publication Type: Journal Article)
• Copyright: Copyright © 2022, Muneshige et al.